Exposure and Dosimetry Considerations for Adverse Outcome Pathways John Wambaugh 0000-0002-4024-534X 10.23645/epacomptox.5078440.v1 https://epa.figshare.com/articles/presentation/Exposure_and_Dosimetry_Considerations_for_Adverse_Outcome_Pathways/5078440 Presented at the Application of New Methods in Risk Science in Regulatory Decision-Making Regarding Chemical Substances 2017-06-30 13:51:46 Dosimetry Exposure High Throughput Toxicokinetics (HTTK) CompTox Toxicology